Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stéphane Ederhy

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Expert Opinion on Pharmacotherapy|October 6, 2006
Optimising stroke prevention in non-valvular atrial fibrillationStéphane Ederhy, Ariel Cohen
Archives of Cardiovascular Diseases|September 17, 2019
Cardio-oncology: Clinical and imaging perspectives for optimal cardiodetection and cardioprotection in patients with cancerFranck Thuny, Olivier Huttin, Stéphane Ederhy
Archives of Cardiovascular Diseases|August 12, 2009
Image. Tricuspid and pulmonary valve involvement in carcinoid heart diseaseStéphane Ederhy, Franck Engel, Ariel Cohen
La Revue Du Praticien|June 23, 2021
[Targeted therapies and high blood pressure]Mélanie Try, Ariel Cohen, Stéphane Ederhy
Thrombosis Research|March 8, 2021
Letter to the editors-in-chief reply to: Solinas et al. Venous and arterial thromboembolic events with immune check point inhibitors: A systematic reviewCorinne Frere, Stéphane Ederhy, Joe-Elie Salem
The New England Journal of Medicine|January 20, 2017
Myocarditis with Immune Checkpoint BlockadeStéphane Ederhy, Anne-Laure Voisin, Stéphane Champiat
Lancet (London, England)|March 24, 2009
Mechanisms of thrombogenesis in atrial fibrillationAriel Cohen, Stéphane Ederhy, Emanuele Di Angelantonio
Lancet (London, England)|March 2, 2024
Investigation of endocarditis finds advanced lung adenocarcinoma: both resolve after tyrosine kinase inhibitor treatmentStéphane Ederhy, Jacques Cadranel, Camille Granger, et al.
Presse Medicale (Paris, France : 1983)|August 25, 2014
[Management of aortic stenosis in patients undergoing non-cardiac surgery]Vincent Labbé, Stéphane Ederhy, Olga Szymkiewicz, et al.
Bulletin Du Cancer|March 31, 2015
[Management of side-effects of targeted therapies in renal cancer: cardiovascular side-effects]Stéphane Ederhy, Brigitte Duclos, Hakim Mahammedi, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Expert Opinion on Pharmacotherapy|October 6, 2006
Optimising stroke prevention in non-valvular atrial fibrillationStéphane Ederhy, Ariel Cohen
Archives of Cardiovascular Diseases|September 17, 2019
Cardio-oncology: Clinical and imaging perspectives for optimal cardiodetection and cardioprotection in patients with cancerFranck Thuny, Olivier Huttin, Stéphane Ederhy
Archives of Cardiovascular Diseases|August 12, 2009
Image. Tricuspid and pulmonary valve involvement in carcinoid heart diseaseStéphane Ederhy, Franck Engel, Ariel Cohen
La Revue Du Praticien|June 23, 2021
[Targeted therapies and high blood pressure]Mélanie Try, Ariel Cohen, Stéphane Ederhy
Thrombosis Research|March 8, 2021
Letter to the editors-in-chief reply to: Solinas et al. Venous and arterial thromboembolic events with immune check point inhibitors: A systematic reviewCorinne Frere, Stéphane Ederhy, Joe-Elie Salem
The New England Journal of Medicine|January 20, 2017
Myocarditis with Immune Checkpoint BlockadeStéphane Ederhy, Anne-Laure Voisin, Stéphane Champiat
Lancet (London, England)|March 24, 2009
Mechanisms of thrombogenesis in atrial fibrillationAriel Cohen, Stéphane Ederhy, Emanuele Di Angelantonio
Lancet (London, England)|March 2, 2024
Investigation of endocarditis finds advanced lung adenocarcinoma: both resolve after tyrosine kinase inhibitor treatmentStéphane Ederhy, Jacques Cadranel, Camille Granger, et al.
Presse Medicale (Paris, France : 1983)|August 25, 2014
[Management of aortic stenosis in patients undergoing non-cardiac surgery]Vincent Labbé, Stéphane Ederhy, Olga Szymkiewicz, et al.
Bulletin Du Cancer|March 31, 2015
[Management of side-effects of targeted therapies in renal cancer: cardiovascular side-effects]Stéphane Ederhy, Brigitte Duclos, Hakim Mahammedi, et al.
Pageof 9